© The Rockefeller University Press, 0022-1007/1997/4/1193/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 7, April 7, 1997 1193-1202
Regulation of T Cell Receptor
Gene Rearrangement by CBF/PEBP2
Pilar Lauzurica,
Xiao-Ping Zhong,
Michael S. Krangel, and
Joseph L. Roberts
From the Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710
We have analyzed transgenic mice carrying versions of a human T cell receptor (TCR)-
gene minilocus to study the developmental control of VDJ (variable/diversity/joining) recombination. Previous data indicated that a 1.4-kb DNA fragment carrying the TCR-
enhancer (E
) efficiently activates minilocus VDJ recombination in vivo. We tested whether the transcription factor CBF/PEBP2 plays an important role in the ability of E
to activate VDJ recombination by analyzing VDJ recombination in mice carrying a minilocus in which the
E3 element of E
includes a mutated CBF/PEBP2 binding site. The enhancer-dependent VD to J step of minilocus rearrangement was dramatically inhibited in three of four transgenic lines, arguing that the binding of CBF/PEBP2 plays a role in modulating local accessibility to the VDJ recombinase in vivo. Because mutation of the
E3 binding site for the transcription factor c-Myb had previously established a similar role for c-Myb, and because a 60-bp fragment of E
carrying
E3 and
E4 binding sites for CBF/PEBP2, c-Myb, and GATA-3 displays significant enhancer activity in transient transfection experiments, we tested whether this fragment of E
is sufficient to activate VDJ recombination in vivo. This fragment failed to efficiently activate the enhancerdependent VD to J step of minilocus rearrangement in all three transgenic lines examined, indicating that the binding of CBF/PEBP2 and c-Myb to their cognate sites within E
, although necessary, is not sufficient for the activation of VDJ recombination by E
. These results imply that CBF/PEBP2 and c-Myb collaborate with additional factors that bind elsewhere within E
to modulate local accessibility to the VDJ recombinase in vivo.
Address correspondence to Dr. Michael S. Krangel, Department of Immunology, PO Box 3010, Duke University Medical Center, Durham, NC 27710. Dr. Lauzurica's present address is Seccion de Inmunologia, Hospital de la Princesa, 28006 Madrid, Spain.
1 Abbreviations used in this paper: D, diversity; J, joining; V, variable.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
del Blanco, B., Roberts, J. L., Zamarreno, N., Balmelle-Devaux, N., Hernandez-Munain, C.
(2009). Flexible Stereospecific Interactions and Composition within Nucleoprotein Complexes Assembled on the TCR{alpha} Gene Enhancer. J. Immunol.
183: 1871-1883
[Abstract]
[Full Text]
-
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., Speck, N. A., Gilliland, D. G.
(2005). Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood
106: 494-504
[Abstract]
[Full Text]
-
Balmelle, N., Zamarreno, N., Krangel, M. S., Hernandez-Munain, C.
(2004). Developmental Activation of the TCR {alpha} Enhancer Requires Functional Collaboration among Proteins Bound Inside and Outside the Core Enhancer. J. Immunol.
173: 5054-5063
[Abstract]
[Full Text]
-
Roumier, C., Eclache, V., Imbert, M., Davi, F., MacIntyre, E., Garand, R., Talmant, P., Lepelley, P., Lai, J. L., Casasnovas, O., Maynadie, M., Mugneret, F., Bilhou-Naberra, C., Valensi, F., Radford, I., Mozziconacci, M. J., Arnoulet, C., Duchayne, E., Dastugue, N., Cornillet, P., Daliphard, S., Garnache, F., Boudjerra, N., Jouault, H., Fenneteau, O., Pedron, B., Berger, R., Flandrin, G., Fenaux, P., Preudhomme, C.
(2003). M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Francais d'Hematologie Cellulaire (GFHC) and the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood
101: 1277-1283
[Abstract]
[Full Text]
-
Hernandez-Munain, C., Krangel, M. S.
(2002). Distinct Roles for c-Myb and Core Binding Factor/Polyoma Enhancer-Binding Protein 2 in the Assembly and Function of a Multiprotein Complex on the TCR {delta} Enhancer In Vivo. J. Immunol.
169: 4362-4369
[Abstract]
[Full Text]
-
Bendall, H. H., Sikes, M. L., Oltz, E. M.
(2001). Transcription Factor NF-{{kappa}}B Regulates Ig{{lambda}} Light Chain Gene Rearrangement. J. Immunol.
167: 264-269
[Abstract]
[Full Text]
-
McMurry, M. T., Krangel, M. S.
(2000). A Role for Histone Acetylation in the Developmental Regulation of V(D)J Recombination. Science
287: 495-498
[Abstract]
[Full Text]
-
Zhong, X.-P., Carabana, J., Krangel, M. S.
(1999). Flanking nuclear matrix attachment regions synergize with the T cell receptor delta enhancer to promote V(D)J recombination. Proc. Natl. Acad. Sci. USA
96: 11970-11975
[Abstract]
[Full Text]